Trial intelligence / Profile preview

Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery

NCT04907812Phase 4Unknown

Start
Jun 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in edema comparing Tranexamic Acid (TXA) with Standard of Care (SOC) (2 arms). Primary endpoints: Adherence to protocol at 12 weeks, Treatment Completion Rate at 12 weeks and 2 more. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

edema

Beyond the preview

Go deeper on NCT04907812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04907812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call